Updated information concerning set-off issue for Bactiguard’s bond loan

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECLTY, IN USA, AUSTRALIA, CANADA, HONG KONG OR JAPAN.

The information regarding the total nominal amount of bonds set-off for shares, which was communicated by Bactiguard Holding AB (publ) (“Bactiguard” or ”the Company”) through press release titled “Set-off issue for Bactiguard’s bond loan”, dated 4 June 2014, has proven to be incorrect. Due to administrative reasons all application forms were not reflected in the count conducted by the banks. Below is updated and final information regarding the outcome of the offset offer.

Of the nominal bond amount of SEK 450 million, holders of bonds totaling a nominal amount of SEK 222.5 million elected to offset their bonds against shares. Following completion of the set-off the Company’s interest expense will be reduced by SEK 24.5 million annually.

Bactiguard Holding AB (publ) is required to disclose the above information under the provisions of the Securities Market Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication at 7.35 AM CET on 5 June 2014.

For further information, please contact:

Fredrik Järrsten - CFO
fredrik.jarrsten@bactiguard.se
+46 725 500 089

Cecilia Edström - Director of Communications
cecilia.edstrom@bactiguard.se
+46 722 262 328

Bactiguard
Bactiguard is a Swedish medtech company with a business concept of preventing healthcare associated infections, reducing the use of antibiotics and saving lives by developing and supplying infection prevention solutions for the healthcare industry. The company’s patented coating prevents healthcare associated infections by reducing bacterial adhesion and growth on medical devices. Bactiguard®-coated urinary catheters are market leading in the US and Japan, and in recent years the company has developed its own product portfolio of coated catheters for the urinary and respiratory tract and the blood stream. Bactiguard is currently in a strong expansion phase, focused on new markets in the EU, Middle East, Asia and South America. The company reported  sales of approximately SEK 130 million in 2013, has 60 employees, headquarters in Stockholm and production facilities in Markaryd and Malaysia. 

Tags: